series-a
Stage
2
Investors
About
Matterworks provides an AI-driven platform that uses large spectral models to interpret biochemical omics data, enabling predictive insights to improve life science R&D across discovery, development, and biomanufacturing.
Explore Matterworks's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.